4.7 Article

Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy

Journal

EUROPEAN HEART JOURNAL
Volume 33, Issue 9, Pages 1128-U49

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehr451

Keywords

Arrhythmogenic right ventricular cardiomyopathy; Lamin A; C gene mutations

Funding

  1. University 'La Sapienza' of Rome
  2. European Society of Cardiology
  3. InGenious Hypercare
  4. EU [QLG1-CT-2000-01091]
  5. British Heart Foundation [RG/04/010]
  6. Department of Health's NIHR Biomedical Research Centres
  7. European Community [Health-2009-2.4.2-3]

Ask authors/readers for more resources

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease predominantly caused by mutations in desmosomal protein genes. Lamin A/C gene (LMNA) mutations are associated with dilated cardiomyopathy, conduction abnormalities and high incidence of sudden cardiac death. In this study, we screened a large cohort of ARVC patients for LMNA mutations. One hundred and eight patients from unrelated families with borderline (n 27) or definite (n 81) diagnosis of ARVC were genetically tested for five desmosomal genes and LMNA. Sixty-one (56.5) were positive for desmosomal gene mutations. Standard polymerase chain reaction (PCR) amplification of the 12 protein-coding LMNA exons was performed and mutational screening performed by direct sequencing. Four patients (4) without desmosomal gene mutations carried LMNA variants. Three had severe right ventricular involvement, and during follow-up three died (two suddenly and one from congestive heart failure); all three had conduction abnormalities on resting 12-lead electrocardiogram (ECG). Myocardial tissue from two patients showed myocyte loss and fibro-fatty replacement. In one of these, immunohistochemical staining with antibody to plakoglobin showed reduced/absent staining of the intercalated discs in the myocardium. Lamin A/C gene mutations can be found in severe forms of ARVC. Lamin A/C gene should be added to desmosomal genes when genetically testing patients with suspected ARVC, particularly when they also have ECG evidence for conduction disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available